Cargando…

Utility of ctDNA in predicting relapse in solid tumors after curative therapy: a meta-analysis

BACKGROUND: Presence of circulating tumor DNA (ctDNA) is prognostic in solid tumors treated with curative intent. Studies have evaluated ctDNA at specific “landmark” or multiple “surveillance” time points. However, variable results have led to uncertainty about its clinical validity. METHODS: A PubM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mittal, Abhenil, Molto Valiente, Consolacion, Tamimi, Faris, Di Iorio, Massimo, Al-Showbaki, Laith, Cescon, David W, Amir, Eitan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317487/ https://www.ncbi.nlm.nih.gov/pubmed/37243731 http://dx.doi.org/10.1093/jncics/pkad040

Ejemplares similares

Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic review
por: Al-Showbaki, Laith, et al.
Publicado: (2023)

Association between control group therapy and magnitude of clinical benefit of cancer drugs
por: Molto, Consolacion, et al.
Publicado: (2022)

Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine and Biologic Treatment Options for Metastatic Hormone Receptor Positive Breast Cancer
por: Mittal, Abhenil, et al.
Publicado: (2023)

Prognostic value of human leukocyte antigen G expression in solid tumors: a systematic review and meta-analysis
por: Bartolome, Jorge, et al.
Publicado: (2023)

Prognostic value of postoperative ctDNA detection in patients with early non-small cell lung cancer: a systematic review and meta-analysis
por: Guo, Kaibo, et al.
Publicado: (2023)

Combining PARP inhibitors and platinum-based chemotherapy in metastatic triple negative and/or BRCA-associated breast cancer
por: Molto Valiente, Consolacion, et al.
Publicado: (2023)

Network Meta-analysis Comparing Efficacy, Safety and Tolerability of Anti-PD-1/PD-L1 Antibodies in Solid Cancers
por: Al-Showbaki, Laith, et al.
Publicado: (2021)

Outcomes of curative esophageal cancer surgery in elderly: A meta-analysis
por: Baranov, Nikolaj S, et al.
Publicado: (2021)

Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy
por: Chen, Jen-Lung, et al.
Publicado: (2023)

Deescalating Adjuvant Trastuzumab in HER2-Positive Early-Stage Breast Cancer: A Systemic Review and Meta-Analysis
por: Goldvaser, Hadar, et al.
Publicado: (2019)

Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis
por: Burgos, Miguel, et al.
Publicado: (2022)

Surrogate endpoint for overall survival in assessment of adjuvant therapies after curative treatment for hepatocellular carcinoma: a re-analysis of meta-analyses of individual patients’ data
por: Huan, Hong-Bo, et al.
Publicado: (2017)

Long-term outcomes of additional surgery versus non-gastrectomy treatment for early gastric cancer after non-curative endoscopic submucosal dissection: a meta-analysis
por: Li, Sixuan, et al.
Publicado: (2023)

Loss of heterozygosity on chromosome 16q increases relapse risk in Wilms’ tumor: a meta-analysis
por: Pan, Zhenyu, et al.
Publicado: (2017)

Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials
por: Shah, Chintan, et al.
Publicado: (2018)

Meta-analysis of the efficacy of treatments for newly diagnosed and relapsed/refractory multiple myeloma with del(17p)
por: Liu, Jinghua, et al.
Publicado: (2017)

Prognostic role of DEK in human solid tumors: a meta-analysis
por: Liu, Gang, et al.
Publicado: (2017)

Treatment-related toxicities of apatinib in solid tumors: a meta-analysis
por: Peng, Ling, et al.
Publicado: (2018)

Predicting STAT1 as a prognostic marker in patients with solid cancer
por: Zhang, Jinguo, et al.
Publicado: (2020)

Efficacy and safety of venetoclax-based regimens for the treatment of relapsed/refractory multiple myeloma: a systemic review and meta-analysis
por: Xu, Linchun, et al.
Publicado: (2023)

The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis
por: Wang, Changwen, et al.
Publicado: (2017)

The prognostic value of NRF2 in solid tumor patients: a meta-analysis
por: Wang, Lingling, et al.
Publicado: (2017)

The prognostic value of p62 in solid tumor patients: a meta-analysis
por: Ruan, Haihua, et al.
Publicado: (2017)

Meta-analysis of the prognostic value of lncRNA ZFAS1 in patients with solid tumors
por: Song, Wei, et al.
Publicado: (2017)

The efficacy and safety of tivantinib in the treatment of solid tumors: a systematic review and meta-analysis
por: Zhang, Hao, et al.
Publicado: (2017)

Systematic review and meta-analysis of the prognostic value of CXCR2 in solid tumor patients
por: Yang, Yong, et al.
Publicado: (2017)

Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis
por: Hansrivijit, Panupong, et al.
Publicado: (2021)

Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma
por: Wang, Ling, et al.
Publicado: (2019)

Homeobox protein CDX2 as a prognostic biomarker in solid malignancies: a meta-analysis
por: Yuan, Jingsheng, et al.
Publicado: (2017)

TACC3 as an independent prognostic marker for solid tumors: a systematic review and meta-analysis
por: Wang, June, et al.
Publicado: (2017)

Prognostic value of Midkine expression in patients with solid tumors: a systematic review and meta-analysis
por: Zhang, Luo, et al.
Publicado: (2018)

APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis
por: Yuan, Chun-Ling, et al.
Publicado: (2017)

Parental Age and Childhood Lymphoma and Solid Tumor Risk: A Literature Review and Meta-Analysis
por: Domingues, Allison, et al.
Publicado: (2022)

Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis
por: Zhang, Xianyun, et al.
Publicado: (2017)

Prognostic role of intratumoral IL-17A expression by immunohistochemistry in solid tumors: a meta-analysis
por: Wang, Shimin, et al.
Publicado: (2017)

Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis
por: Zhong, Jie-Hui, et al.
Publicado: (2017)

Prognostic role of tumor-infiltrating CD57-positive lymphocytes in solid tumors: a meta-analysis
por: Hu, Guoming, et al.
Publicado: (2017)

Prognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review
por: Wang, Rong, et al.
Publicado: (2017)

Radiotherapy and Receptor Tyrosine Kinase Inhibition for Solid Cancers (ROCKIT): A Meta-Analysis of 13 Studies
por: Tchelebi, Leila T, et al.
Publicado: (2021)

Upregulated SOX9 expression indicates worse prognosis in solid tumors: a systematic review and meta-analysis
por: Ruan, Haihua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hadbvv5gk53pdq4ekdk6u58ktk